Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionAuxier Asset Management
Latest Disclosed Ownership8,910 shares
Latest Disclosed Value $ 3,134,983
Auxier Asset Management ownership in AMGN / Amgen Inc.

On May 14, 2026 - Auxier Asset Management filed a 13F-HR form disclosing ownership of 8,910 shares of Amgen Inc. (CH:AMGN) valued at $3,134,983 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 8,910 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Amgen COM 031162100 8,910 0 0.00 3,135 7.48 0.4502
2026-02-17 2025-12-31 13F Amgen COM 031162100 8,910 -200 -2.20 2,916 13.46 0.4101
2025-11-19 2025-09-30 13F Amgen COM 031162100 9,110 0 0.00 2,571 1.06 0.3603
2025-08-15 2025-06-30 13F Amgen COM 031162100 9,110 -125 -1.35 2,544 -11.61 0.3736
2025-05-14 2025-03-31 13F Amgen COM 031162100 9,235 -50 -0.54 2,877 18.88 0.4288
2025-02-19 2024-12-31 13F Amgen COM 031162100 9,285 575 6.60 2,420 -13.76 0.3751
2024-11-14 2024-09-30 13F Amgen COM 031162100 8,710 -5 -0.06 2,806 3.05 0.4148
2024-08-13 2024-06-30 13F Amgen COM 031162100 8,715 -300 -3.33 2,723 6.24 0.4311
2024-05-08 2024-03-31 13F Amgen COM 031162100 9,015 0 0.00 2,563 -1.27 0.3899
2024-02-22 2023-12-31 13F Amgen COM 031162100 9,015 -375 -3.99 2,596 2.89 0.4201
2023-11-21 2023-09-30 13F Amgen COM 031162100 9,390 -18 -0.19 2,524 20.83 0.4306
2023-08-17 2023-06-30 13F Amgen COM 031162100 9,408 300 3.29 2,089 -5.13 0.3466
2023-05-15 2023-03-31 13F Amgen COM 031162100 9,108 200 2.25 2,202 -5.90 0.3800
2023-02-17 2022-12-31 13F Amgen COM 031162100 8,908 0 0.00 2,340 16.48 0.4038
2022-11-15 2022-09-30 13F Amgen COM 031162100 8,908 0 0.00 2,008 -7.34 0.3869
2022-08-11 2022-06-30 13F Amgen COM 031162100 8,908 0 0.00 2,167 0.60 0.3870
2022-05-17 2022-03-31 13F Amgen COM 031162100 8,908 0 0.00 2,154 7.49 0.3416
2022-03-01 2021-12-31 13F Amgen COM 031162100 8,908 204 2.34 2,004 8.27 0.3111
2021-11-18 2021-09-30 13F Amgen COM 031162100 8,704 3,456 65.85 1,851 44.72 0.3132
2021-08-18 2021-06-30 13F Amgen COM 031162100 5,248 0 0.00 1,279 -2.07 0.2120
2021-05-17 2021-03-31 13F Amgen COM 031162100 5,248 120 2.34 1,306 10.77 0.2246
2021-03-05 2020-12-31 13F Amgen COM 031162100 5,128 0 0.00 1,179 -9.52 0.2188
2021-03-05 2020-09-30 13F Amgen COM 031162100 5,128 -30 -0.58 1,303 7.07 0.2725
2020-08-20 2020-06-30 13F Amgen COM 031162100 5,158 0 0.00 1,217 16.35 0.2685
2020-05-15 2020-03-31 13F Amgen COM 031162100 5,158 -1,000 -16.24 1,046 -29.56 0.2612
2020-02-21 2019-12-31 13F Amgen COM 031162100 6,158 -50 -0.81 1,485 23.65 0.2764
2019-11-15 2019-09-30 13F Amgen COM 031162100 6,208 100 1.64 1,201 6.66 0.2416
2019-08-15 2019-06-30 13F Amgen COM 031162100 6,108 0 0.00 1,126 -2.93 0.2246
2019-05-14 2019-03-31 13F Amgen COM 031162100 6,108 0 0.00 1,160 -2.44 0.2383
2019-02-13 2018-12-31 13F Amgen COM 031162100 6,108 -20 -0.33 1,189 -6.38 0.2648
2018-11-19 2018-09-30 13F Amgen COM 031162100 6,128 0 0.00 1,270 12.29 0.2395
2018-08-15 2018-06-30 13F Amgen COM 031162100 6,128 1,070 21.15 1,131 31.21 0.2264
2018-05-14 2018-03-31 13F Amgen COM 031162100 5,058 1,718 51.44 862 48.36 0.1726
2018-02-14 2017-12-31 13F Amgen COM 031162100 3,340 40 1.21 581 -5.53 0.1115
2017-11-09 2017-09-30 13F Amgen COM 031162100 3,300 0 0.00 615 8.27 0.1249
2017-08-16 2017-06-30 13F Amgen COM 031162100 3,300 2,000 153.85 568 166.67 0.1160
2017-05-12 2017-03-31 13F Amgen COM 031162100 1,300 1,300 213 0.0446
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.